Avalon Ventures XI, L.P.

Average Profitability
1.61%
Insider Buys Quantity
2
Insider Buys Sum
$15.69M
Insider Sells Quantity
11
Insider Sells Sum
$205.38M

Insider Activity of Avalon Ventures XI, L.P.

According to the SEC Form 4 filings, Avalon Ventures XI, L.P., being in a position of

  1. 10 percent owner at Janux Therapeutics, Inc.,
    оver the last 12 months, has bought 849854 shares for $4.99M, and sold 4174180 shares for $205.38M,
    over all time since 2021-06-15, has bought 1479265 shares for $15.69M, and sold 4174180 shares for $205.38M.

The largest purchase of all time was on 2021-06-15 and amounted to 629411 share of Janux Therapeutics, Inc. for $10.7M.

The largest sale of all time was on 2024-06-03 and amounted to 1500000 shares of Janux Therapeutics, Inc. for $82.13M.

Biography of Avalon Ventures XI, L.P.

No biography is available at this moment.

2024-10-18SaleJanux Therapeutics, Inc.
JANX
10 percent owner
1.46M
2.5633%
$45.76$66.9M+8.53%
2024-10-17SaleJanux Therapeutics, Inc.
JANX
10 percent owner
1,843
0.0035%
$50.02$92,187+8.83%
2024-10-16SaleJanux Therapeutics, Inc.
JANX
10 percent owner
209,516
0.4311%
$50.03$10.48M+9.49%
2024-09-30SaleJanux Therapeutics, Inc.
JANX
10 percent owner
958
0.0018%
$46.24$44,298+8.91%
2024-09-27SaleJanux Therapeutics, Inc.
JANX
10 percent owner
106,821
0.2041%
$46.46$4.96M+6.83%
2024-09-26SaleJanux Therapeutics, Inc.
JANX
10 percent owner
200,000
0.3603%
$47.23$9.45M-0.89%
2024-09-12SaleJanux Therapeutics, Inc.
JANX
10 percent owner
350,000
0.6777%
$47.00$16.45M+6.49%
2024-09-10SaleJanux Therapeutics, Inc.
JANX
10 percent owner
101,091
0.1981%
$46.53$4.7M+8.75%
2024-09-09SaleJanux Therapeutics, Inc.
JANX
10 percent owner
2,182
0.0042%
$42.33$92,364+18.18%
2024-09-06SaleJanux Therapeutics, Inc.
JANX
10 percent owner
240,000
0.4683%
$42.00$10.08M+19.81%
2024-06-03SaleJanux Therapeutics, Inc.
JANX
10 percent owner
1.5M
2.8808%
$54.75$82.13M-18.76%
2023-11-13PurchaseJanux Therapeutics, Inc.
JANX
10 percent owner
849,854
1.538%
$5.87$4.99M+483.1%
2021-06-15PurchaseJanux Therapeutics, Inc.
JANX
10 percent owner
629,411
5.7397%
$17.00$10.7M+1.61%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.